Finger skin blood perfusion during exposure of ulnar and median nerves to the static magnetic field of a rare-earth magnet: A randomized pilot study

Author(s):  
Harvey N. Mayrovitz ◽  
Andrea Astudillo ◽  
Elham Shams
2018 ◽  
Vol 5 (4) ◽  
pp. 400-410 ◽  
Author(s):  
Yang Yang ◽  
Liangxiao Ma ◽  
Tingli Niu ◽  
Junxiang Wang ◽  
Yue Song ◽  
...  

2017 ◽  
Vol 158 ◽  
pp. 13-17 ◽  
Author(s):  
Junfeng Wang ◽  
Dongmei Zhu ◽  
Xihui Fang ◽  
Tingsheng Qiu ◽  
Yanbo Liu ◽  
...  

2014 ◽  
Vol 11 (98) ◽  
pp. 20140601 ◽  
Author(s):  
Márk Juhász ◽  
Viktor L. Nagy ◽  
Hajnal Székely ◽  
Dorottya Kocsis ◽  
Zsolt Tulassay ◽  
...  

This pilot study was devoted to the effect of static magnetic field (SMF)-exposure on erosive gastritis. The randomized, self- and placebo-controlled, double-blind, pilot study included 16 patients of the 2nd Department of Internal Medicine, Semmelweis University diagnosed with erosive gastritis. The instrumental analysis followed a qualitative (pre-intervention) assessment of the symptoms by the patient: lower heartburn (in the ventricle), upper heartburn (in the oesophagus), epigastric pain, regurgitation, bloating and dry cough. Medical diagnosis included a double-line upper panendoscopy followed by 30 min local inhomogeneous SMF-exposure intervention at the lower sternal region over the stomach with peak-to-peak magnetic induction of 3 mT and 30 mT m −1 gradient at the target site. A qualitative (post-intervention) assessment of the same symptoms closed the examination. Sham- or SMF-exposure was used in a double-blind manner. The authors succeeded in justifying the clinically and statistically significant beneficial effect of the SMF- over sham-exposure on the symptoms of erosive gastritis, the average effect of inhibition was 56% by p = 0.001, n = 42 + 96. This pilot study was aimed to encourage gastroenterologists to test local, inhomogeneous SMF-exposure on erosive gastritis patients, so this intervention may become an evidence-based alternative or complementary method in the clinical use especially in cases when conventional therapy options are contraindicated.


Cureus ◽  
2021 ◽  
Author(s):  
Harvey Mayrovitz ◽  
Brittany Milo ◽  
Brooke Alexander ◽  
Marisa Mastropasqua ◽  
Yashaswani Moparthi

2018 ◽  
Author(s):  
Jyoti Shaw ◽  
Ayan Chakraborty ◽  
Sanjoy Chatterjee ◽  
Maitreyee Bhattacharyya ◽  
Anjan Kr Dasgupta

AbstractStatic magnetic field (SMF) is reported to mimic chelation agents. In thalassemia blood, SMF minimizes iron overloading effect. In such cells ROS level is reduced, in presence of moderate strength (70mT). Pilot study on transfusion dependent thalassemia, thalassemia carriers and normal red blood clearly indicate the differential effects of SMF on thalassemia, thalassemia carrier and normal cells. SMF also reduces ROS induced DNA damage in lymphocytes. A comparative study on the iron chelating drug deferasirox and SMF treated lymphocytes further confirm our main thesis. This non-invasive therapeutic regime for hemochromatosis may serve the dual purpose of treating, iron overloading and minimizing, cellular damage by lowering the ROS level.


Sign in / Sign up

Export Citation Format

Share Document